Abstract Search

ea0006oc22 | Growth and Development | SFE2003

REASSESSMENT OF GROWTH HORMONE STATUS IS REQUIRED AT FINAL HEIGHT IN CHILDREN TREATED WITH GROWTH HORMONE REPLACEMENT FOLLOWING RADIATION THERAPY

Gleeson H , Gattamaneni H , Smethurst L , Brennan B , Shalet S

The most appropriate way to manage growth hormone replacement (GH) in the transition to adulthood in children treated with GH for GH deficiency (GHD) is controversial. The GH Research Society suggest that retesting of GH status at final height (FH) is unnecessary in the presence of 'severe organic GHD' and cranial irradiation falls into this etiological category. This recommendation has never been validated.To investigate whether patients diagnosed in ch...

0 shares

ea0019p106 | Clinical practice/governance and case reports | SFEBES2009

The challenges of implementing consensus recommendations for GH therapy in GHD adolescent survivors of childhood cancer during the transition period

Gleeson H , Whitehouse A , Smethurst L , Shalet S , Brennan B , Clayton P

Background: Re-evaluation of the diagnosis of GHD at the completion of linear growth is a key task.Objectives: To audit the impact of consensus recommendations on diagnosis of GHD and initiation of GH therapy in adolescents previously treated for a brain tumour (BT) or haematological malignancy (HM).Population: Sixty one patients who had received GH therapy until final height following treatment for a BT (n=40) or a HM (n...

0 shares

Endocrine Abstracts

REASSESSMENT OF GROWTH HORMONE STATUS IS REQUIRED AT FINAL HEIGHT IN CHILDREN TREATED WITH GROWTH HORMONE REPLACEMENT FOLLOWING RADIATION THERAPY

The challenges of implementing consensus recommendations for GH therapy in GHD adolescent survivors of childhood cancer during the transition period

BiosciAbstracts